Skip to main content
. 2024 Aug 15;18(8):e0012409. doi: 10.1371/journal.pntd.0012409

Fig 4. Duration of illness and number of lesions.

Fig 4

A. Duration of illness in months for each clinical presentation in adult CL patients (LCL: n = 144, MCL: n = 49, DCL: n = 4, recidivans: n = 1, multiple CL: n = 8); this information was missing for 1 LCL patient. B. Duration of illness in months for each clinical presentation in child CL patients (LCL: n = 94, MCL: n = 21, DCL: n = 1, recidivans: n = 5, multiple CL: n = 12); this information was missing for 4 LCL and 2 MCL patients. C. Number of lesions for each clinical presentation in adult CL patients (LCL: n = 145, MCL: n = 49, DCL: n = 4, recidivans: n = 1, multiple CL: n = 8). D. Number of lesions for each clinical presentation in child CL patients (LCL: n = 98, MCL: n = 23, DCL: n = 1, recidivans: n = 5, multiple CL: n = 12). E. Number of lesions in adult S (n = 105) and S (n = 40) LCL patients. In Fig 4A, 4B, 4C and 4D, statistical differences between the five different clinical presentations of CL were measured by Kruskal-Wallis test and the multiple comparison between each clinical presentation using Dunn’s multiple comparison test. In Fig 4E, statistical difference between S and C LCL was determined using a Mann-Whitney test. The straight line represents the median. Only significant differences were annotated, in the absence of *, the differences were not significant.